Pharmaceutical Technology20 天
Axatilimab by Incyte for Solid Tumor: Likelihood of Approval
Axatilimab is under clinical development by Incyte and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success rate (PTSR) ...
Pharmaceutical Technology14 天
Sotorasib by Amgen for Solid Tumor: Likelihood of Approval
Sotorasib is under clinical development by Amgen and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success rate (PTSR) ...